LyondellBasell Industries N.V. LYB

Healthcare SIC 2860 - Industrial Organic Chemicals NYSE

and 2. Business and Properties.

LyondellBasell Industries N.V. is a global, independent chemical company and was incorporated, as a Naamloze Vennootschap, under Dutch law on October 15, 2009. Unless otherwise indicated, the "Company," "we," "our," "us" and "LyondellBasell" are used in this report to refer to the businesses of LyondellBasell Industries N.V. and its consolidated subsidiaries.

We participate globally across the petrochemical value chain and are an industry leader in many of our product lines. Our chemicals businesses consist primarily of large processing plants that convert large volumes of liquid and gaseous hydrocarbon feedstocks into plastic resins and other chemicals. Our chemical products tend to be basic building blocks for other chemicals and plastics. Our plastic products are used in large volumes as well as smaller specialty applications. Our customers use our plastics and chemicals to manufacture a wide range of products that people use in their everyday lives, including food packaging, home furnishings, automotive components, paints and coatings. We also develop and license chemical and polyolefin process technologies, and manufacture and sell polyolefin catalysts.

Last close 63.52 2026-09-04
Market cap $20.52B 2026-06-30 share count
52-week range 41.58 - 83.94

Valuation FY2025 figures against the last close

P/S0.7x
P/E
P/FCF53.4x
EV/EBITDA15.7x
Dividend yield8.6%
Diluted EPS-2.34

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $30.15B$33.39B$33.34B$50.45B$46.17B$27.00B$33.91B$38.13B$33.70B$28.45B
Cost of revenue $27.58B$28.75B$28.43B$43.85B$37.40B$24.36B$29.30B$32.53B$28.06B$23.19B
Gross profit $2.58B$4.64B$4.90B$6.60B$8.78B$2.64B$4.61B$5.60B$5.65B$5.26B
R&D $136.0M$135.0M$130.0M$124.0M$124.0M$113.0M$111.0M$115.0M$106.0M$99.0M
SG&A $1.61B$1.64B$1.54B$1.31B$1.25B$1.14B$1.20B$1.13B$859.0M$833.0M
Total operating expenses $30.57B$31.48B$30.61B$45.35B$39.40B$26.19B$30.61B$33.77B$29.02B$24.12B
Operating income -$420.0M$1.92B$2.73B$5.10B$6.77B$1.56B$4.12B$5.23B$5.46B$5.06B
Interest expense $487.0M$481.0M$477.0M$287.0M$519.0M$526.0M$347.0M$360.0M$491.0M$322.0M
Pre-tax income -$715.0M$1.70B$2.30B$4.78B$6.79B$1.39B$4.05B$5.31B$5.49B$5.23B
Income tax $70.0M$259.0M$433.0M$882.0M$1.16B$43.0M$648.0M$613.0M$598.0M$1.39B
Net income -$738.0M$1.37B$2.12B$3.89B$5.62B$1.43B$3.40B$4.69B$4.88B$3.84B
EPS, basic -2.344.166.4811.8416.774.249.5912.0412.239.15
EPS, diluted -2.344.156.4611.8116.754.249.5812.0112.239.13

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $3.44B$3.38B$3.40B$2.16B$1.48B$1.76B$888.0M$401.0M$1.53B$878.0M
Short-term investments $2.03B$2.61B$2.43B$1.19B$9.0M$702.0M$196.0M$892.0M$1.31B$1.15B
Receivables $3.39B$4.57B$3.29B$2.98B$3.35B$3.36B$2.72B
Inventory $3.53B$4.66B$4.76B$4.80B$4.90B$4.34B$4.59B$4.51B$4.22B$3.81B
Total current assets $10.87B$12.27B$13.15B$11.85B$12.22B$11.63B$9.51B$10.57B$11.74B$9.60B
Property, plant and equipment $15.83B$15.07B$15.55B$15.39B$14.56B$14.39B$14.13B$12.48B$11.00B$10.14B
Goodwill $708.0M$1.56B$1.65B$1.83B$1.88B$1.95B$1.89B$1.81B$570.0M$528.0M
Other intangibles $450.0M$577.0M$641.0M$662.0M$695.0M$751.0M$869.0M$965.0M$568.0M$550.0M
Total assets $34.00B$35.75B$37.00B$36.37B$36.74B$35.40B$30.43B$28.28B$26.21B$23.44B
Short-term debt $226.0M$119.0M$117.0M$349.0M$362.0M$663.0M$445.0M$885.0M$68.0M$594.0M
Total current liabilities $6.13B$6.71B$7.15B$6.76B$7.23B$5.50B$5.20B$5.51B$4.78B$4.54B
Retained earnings $6.81B$9.32B$9.69B$9.20B$8.56B$4.44B$4.43B$6.76B$15.75B$12.28B
Total equity $10.08B$12.46B$12.93B$12.62B$11.86B$7.97B$8.04B$10.26B$8.95B$6.05B

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $2.26B$3.82B$4.94B$6.12B$7.70B$3.40B$4.96B$5.47B$5.21B$5.61B
Depreciation and amortisation $1.39B$1.52B$1.53B$1.27B$1.39B$1.39B$1.31B$1.24B$1.17B$1.06B
Stock-based compensation $91.0M$91.0M$91.0M$70.0M$66.0M$55.0M$48.0M$39.0M$55.0M$38.0M
Capital expenditure $1.88B$1.84B$1.53B$1.89B$1.96B$1.95B$2.69B$2.10B$1.55B$2.24B
Investing cash flow -$1.78B-$1.85B-$1.78B-$1.98B-$1.50B-$4.91B-$1.64B-$3.56B-$1.76B-$2.30B
Financing cash flow -$507.0M-$1.90B-$1.95B-$3.41B-$6.38B$2.27B-$2.83B-$3.01B-$2.86B-$3.35B
Dividends paid $1.76B$1.72B$1.61B$3.25B$1.49B$1.41B$1.46B$1.55B$1.42B$1.40B
Buybacks $201.0M$195.0M$211.0M$420.0M$463.0M$4.0M$3.75B$1.85B$866.0M$2.94B

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001308179-26-000250.

Others in SIC 2860

TickerCompanyMarket capP/ERevenue growth
IFF INTERNATIONAL FLAVORS & FRAGRANCES INC $22.03B -5.2%
WLK WESTLAKE CORP $9.56B -8.0%
NEU NEWMARKET CORP $8.14B 19.9x -2.2%
SXT SENSIENT TECHNOLOGIES CORP $5.74B 42.7x 3.5%
REX REX AMERICAN RESOURCES Corp $1.38B 16.6x 1.2%
GPRE Green Plains Inc. $1.08B 16.0%
WLKP Westlake Chemical Partners LP $771.2M 2.7%
GEVO Gevo, Inc. $405.5M 849.3%